Liftear (Lifitegrast INN)
Therapeutic Group : Immunomodulator & LFA-1 Antagonist Presentation: Liftear Ophthalmic Solution: Each ml contains Lifitegrast INN 50 mgPreservative: Sodium Perborate BP 0.01% Pharmacology: Lifitegrast is a novel lymphocyte function associated antigen 1 (LFA-1) antagonist. Itacts by inhibiting LFA-1 interaction with the intercellular adhesion molecule (ICAM)-1on the T-cell surface, inhibiting T-cell adhesion, migration, activation and subsequentcytokine […]